Urinary catecholamine excretion and behavioral differences in ADHD and normal boys

Journal of Child and Adolescent Psychopharmacology

Volumn 6, Issue 1, 1996, Pages 63-73

  Hanna, Gregory L ^a   Ornitz, Edward M ^b   Hariharan, M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; ADRENALIN; CATECHOLAMINE;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERACTIVITY; MALE; SCHOOL CHILD; URINE;

EID: 0029938635     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1996.6.63     Document Type: Article

References (51)

1. Achenbach TM: Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington, VT, University of Vermont Department of Psychiatry, 1991
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, D.C., American Psychiatric Press, 1987
3. Baines AD, Drangova R: Neural not tubular dopamine increases glomerular filtration rate in perfused rat kidneys. Am J Physiol 250:F674-F679, 1986
4. Baines AD, Drangova R, Hatcher C: Dopamine production by isolated glomeruli and tubules from rat kidneys. Can J Physiol Pharmacol 63:155-158, 1985
5. Baum AS, Lundberg U, Grunberg NE, Singer JE, Gatchel RJ: Urinary catecholamines in behavioral research on stress. In: The Catecholamines in Psychiatric and Neurologic Disorders. Edited by Lake CR, Ziegler MG. Boston, Butterworth, 1985, pp 55-72
6. Castellanos FX, Elia J, Kruesi MJP, Gulotta CS, Mefford IN, Potter WZ, Ritchie GF, Rapoport JL: Cerebrospinal fluid monoamine metabolites in boys with attention deficit hyperactivity disorder. Psychiat Res 52:305-316, 1994
7. Cedarbaum JM, Aghajanian GK: Noradrenergic neurons of the locus coeruleus: Inhibition of epinephrine and activation by the alph-agonist piperoxane. Brain Res 112:413-419, 1976
8. Cryer PE: Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 303:436-444, 1980
9. Dienstbier RA: Arousal and physiological toughness: Implications for mental and physical health. Psychol Rev 96:84-100, 1989
10. Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS: Stimulant drug treatment of hyperactivity: Biochemical correlates. Clin Pharmacol Ther 48:57-66, 1990
11. Elwood SW, Ferguson HB, Thakar J: Catecholamine response of children in a naturally occurring stressor situation. J Human Stress 12:154-161, 1986
12. Ernst M, Zametkin AJ: The interface of genetics, neuroimaging, and neurochemistry in attention-deficit hyperactivity disorder. In: Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. Raven Press, New York, 1995, pp 1643-1652
13. Esler M, Jennings G, Lambert G: Measurement of overall and cardiac norepinephrine release into plasma during cognitive challenge. Psychoneuroendocrinology 14:477-481, 1989
14. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G: Overflow of catecholamine neurotransmitters to the circulation: Source, fate, and functions. Physiol Rev 70:963-985, 1990
15. Esler M, Jennings G, Leonard P, Sacharias N, Burke F, Johns J, Blombery P: Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand Suppl 527:11-16, 1984
16. Forsman L: Note on estimating catecholamines in urine sampled after 75 minute periods of mental work and inactivity. J Psychosom Res 25:223-225, 1981
17. Frankenhaeuser M, Jarpe G, Matell G: Effects of intravenous infusions of adrenaline and noradrenaline on certain psychological and physiological functions. Acta Physiol Scand 51:175-186, 1961
18. Frankenhaeuser M, Johansson G: Behavior and catecholamines in children. In: Society, Stress and Disease, Vol. 2, Childhood and Adolescence. Edited by Levi L. London, Oxford University Press, 1975, pp 118-126
19. Goldstein DS, Stull R, Zimlichman R, Levinson PD, Smith H, Keiser HR: Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection. Clin Chem 30:815-816, 1984
20. Johansson G, Frankenhaeuser M, Magnusson D: Catecholamine output in school children as related to performance and adjustment. Scand J Psychol 14:20-28, 1973
21. Khan AU, Dekirmenjian H: Urinary excretion of catecholamine metabolites in hyperkinetic children. Am J Psychiat 138:108-112, 1981
22. Klinteberg BA, Magnusson D: Aggressiveness and hyperactive behavior as related to adrenaline excretion. [Special Issue: Personality and Aggression.] Eur J Personality 3:81-93, 1989
23. Kopin IJ: Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol Rev 37:333-364, 1985
24. Kopp U, Bradley T, Hjemdahl P: Renal venous overflow and urinary excretion of norepinephrine, epinephrine, and dopamine during graded renal nerve stimulation. Am J Physiol 244:E52-E60, 1983
25. Loney J, Milich M: Hyperactivity, inattention, and aggression in clinical practice. In: Advances in Behavioral and Developmental Pediatrics, Vol. 3. Edited by Wolraich M, Routh DK. Greenwich, CT, JAI, 1982, pp 113-147
26. McCracken JT: A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. J Neuropsychiatry Clin Neurosci 3:201-209, 1991
27. McCracken JT, Hinshaw S, Henker B, Whalen CK, Zupan B: Urinary catecholamine differences in ADHD versus normal children and effects of methylphenidate [abstract]. Annual Meeting, Society for Research in Child and Adolescent Psychopathology, Irvine, CA, 1990
28. Mefford IN, Potter WZ: A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: A defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation. Med Hypotheses 29:33-42, 1989
29. Mefford IN, Ward MM, Miles L, Taylor B, Chesney MA, Keegan DL, Barchas JD: Determination of plasma catecholamines and free 3,4-dihydroxyphenylacetic acid in continuously collected human plasma by high performance liquid chromatography with electrochemical detection. Life Sci 28:477-483, 1981
30. Mikkelsen E, Lake CR, Brown GL, Ziegler MG, Ebert MH: The hyperactive child syndrome: Peripheral sympathetic nervous system function and the effect of d-amphetamine. Psychiat Res 4:157-169, 1981
31. Oades RD: Attention deficit disorder with hyperactivity (ADDH): The contribution of catecholaminergic activity. Prog Neurobiol 29:365-391, 1987
32. Ornitz EM, Hanna GL, de Traversay J: Prestimulation-induced startle modulation in attention-deficit hyperactivity disorder and nocturnal enuresis. Psychophysiology 29:437-451, 1992
33. Parra A, Ramirez del Angel A, Cervantes C, Sanchez M: Urinary excretion of catecholamines in healthy subjects in relation to body growth. Acta Endocr 94:546-551, 1980
34. Pliszka SR, Maas JW, Javors MA, Rogeness GA, Baker J: Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiat 33:1165-1173, 1994
35. Rapoport JL, Lott I, Alexander D, Abramson A: Urinary noradrenaline and playroom behavior in hyperactive boys. Lancet 2:1141, 1970
36. Rapoport JL, Mikkelsen EJ, Ebert MH, Brown GL, Weise VK, Kopin IJ: Urinary catecholamine and amphetamine excretion in hyperactive and normal boys. J Nerv Ment Dis 166:731-737, 1978
37. Rogeness G, Javors MA, Pliszka SR: Neurochemistry and child and adolescent psychiatry. J Am Acad Child Adolesc Psychiat 31:765-781, 1992
38. Shah S, Tse TF, Clutter WE, Cryer PE: The human sympathochromaffin system. Am J Physiol 247:E380-E384, 1984
39. Shaywitz BA, Cohen DJ, Bowers MB: CSF monoamine metabolites in children with minimal brain dysfunction: Evidence for alteration of brain dopamine. J Pediat 90:67-71, 1977
40. Shekim WO, Dekirmenjian H, Chapel JL: Urinary catecholamine metabolites in hyperkinetic boys treated with d-amphetamine. Am J Psychiat 134:1276-1279, 1977
41. Shekim WO, Dekirmenjian H, Chapel JL, Javaid J, Davis JM: Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine. Am J Psychiat 136:667-671, 1979
42. Shekim WO, Javaid J, Davis JM, Bylund DB: Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Biol Psychiat 18:707-714, 1983
43. Shetty T, Chase TN: Central monoamines and hyperactivity of childhood. Neurology 26:1000-1006, 1976
44. Stolk JM, Vantini G, Perry BD, Guchait RB, U'Prichard DC: Assessment of the functional role of brain adrenergic neurons: Chronic effects of phenylethanolamine-N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism. J Pharmacol Exp Ther 230:577-586, 1984
45. Tennes K, Kreye M, Avitable N, Wells R: Behavioral correlates of excreted catecholamines and cortisol in second-grade children. J Am Acad Child Psychiat 25:764-770, 1986
46. Ullmann RK, Sleator EK, Sprague RL: Introduction to the use of ACTeRS. Psychopharm Bull 21:915-920, 1985
47. Wechsler D: Wechsler Intelligence Scale for Children-Revised. New York, Psychological Corporation, 1974
48. Welner Z, Rich W, Herjanic B, Jung K, Amado H: Reliability, validity, and child agreement studies of the Diagnostic Interview for Children and Adolescents (DICA). J Am Acad Child Adolesc Psychiat 26:649-653, 1987
49. Wender P, Epstein RS, Kopin IH, Gordon EK: Urinary monoamine metabolites in children with minimal brain dysfunction. Am J Psychiat 127:1411-1415, 1971
50. Yu-cun S, Yu-feng W: Urinary 3-methoxy-4-hydroxyphenylglycol sulfate in seventy-three schoolchildren with minimal brain dysfunction syndrome. Biol Psychiat 19:861-870, 1984
51. Zametkin AJ, Rapoport JL: Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years? J Am Acad Child Adolesc Psychiat 26:676-686, 1987